Local esterase activity within the tumor cleaves off the bulky PEG moiety and releases SN38, which passes the plasma membrane and inhibits nuclear topoisomerase I. ABCG2 is apparently not a sufficiently effective defense mechanism against sustained SN38 delivery by EZN-2208. Here, ABCG2 is linked to neoplasm.